VALIDATED RP-HPLC METHOD FOR THE DETERMINATION OF IVABRADINE HYDROCHLORIDE IN PHARMACEUTICAL FORMULATION

Authors

  • Md. Muzaffar-ur- Rehman Department of Pharmaceutical Analysis, St. Mary’s College of Pharmacy, Secunderabad-500025, Telangana, India
  • G. Nagamallika Department of Pharmaceutical Chemistry, St. Paul’s College of Pharmacy, Turkayamjal (V), Nagarjuna Sagar Road, R.R. Dist, Hyderabad-501 510, Telangana State, India

Abstract

A simple, rapid, precise, and accurate RP-HPLC method for the estimation of Ivabradine Hydrochloride an anti-anginal agent, both as a bulk drug and in pharmaceutical formulation was developed. The chromatographic separation was achieved on a Thermosil C18 150 × 4.5 mm, 5μm column by using a mobile phase containing a mixture of methanol and phosphate buffer pH 6.5 in the ratio of 65:35 % v/v at a flow rate of 1ml/min and at an ambient temperature. The detection was monitored at a wavelength of 265nm. A clear chromatographic peak was identified with the retention time of 4.36 min and tailing factor of 1.23. The developed method was validated according to ICH guidelines with respect to specificity, linearity, accuracy, precision and robustness. The method shows a good linear relationship with correlation co-efficient of more than 0.992 in the concentration range of 30µg-150µg. The method showed mean % Recovery of 100.4% and %RSD for repeatability and intermediate precision was less than 2%. The proposed method can be used successfully for the quantitative determination of Ivabradine HCL in pharmaceutical dosage forms.

Keywords:

Ivabradine hydrochloride, ICH guidelines, Estimation, Capsules, RP-HPLC.

DOI

https://doi.org/10.25004/IJPSDR.2017.090505

References

1. De Silva R, Fox KM. Angina: ivabradine for treatment of stable angina pectoris. Nature Reviews Cardiology. 2009 May 1; 6(5):329-30.
2. Postea O, Biel M. Exploring HCN channels as novel drug targets. Nature reviews. Drug discovery. 2011 Dec 1; 10(12):903.
3. DiFrancesco D. Cardiac pacemaker/f current and its inhibition by heart rate-reducing agents. Current medical research and opinion. 2005 Jul 1; 21(7):1115-22.
4. Seerapu S, Srinivasan BP. Development and validation of RP-HPLC method for the estimation of ivabradine hydrochloride in tablets. Indian journal of pharmaceutical sciences. 2010 Sep; 72(5):667.
5. Rahman R, Asaduzzaman MD, Ashraful SM. Development and validation of RP-HPLC method for analysis of Ivabradine Hydrochloride in tablet dosage forms. Res J Pharm Biol Chem Sci. 2012; 3:1034-43.
6. Motisariya MH, Patel KG, Shah PA. Validated stability-indicating high performance thin layer chromatographic method for determination of Ivabradine hydrochloride in bulk and marketed formulation: an application to kinetic study. Bulletin of Faculty of Pharmacy, Cairo University. 2013 Dec 31; 51(2):233-41.
7. Maheshwari S, Khandhar AP, Jain A. Quantitative determination and validation of ivabradine HCl by stability indicating RP-HPLC method and spectrophotometric method in solid dosage form. Eurasian Journal of Analytical Chemistry. 2010 Mar 9; 5(1):53-62.
8. Selva Kumar P, Rajagopal K. Development and Validation of Stability Indicating HPLC method for estimation of related substances in ivabradine hydrochloride in solid oral dosage form. World Journal of Pharmacy and Pharmaceutical Sciences. 2015; 4(9): 1841-1853.
9. Damle MC, Bagwe RA. Development and validation of stability-indicating HPTLC method for ivabradine HCl. Pharm Sci Monitor. 2015 Jan 1; 6(1):141-52.
10. Patel H, Jivani N. Development of Validated RP-HPLC method for simultaneous estimation of carvedilol and ivabradine. World Journal of Pharmacy and Pharmaceutical Sciences. 2015; 4(5): 630-639.
11. Mostafa NM, Fayez YM, Farid JF, Abd El-Alim AE. Stability Indicating Spectrophotometric Methods for Determination of Ivabradine Hydrochloride in the Presence of Its Degradation Product. Analytical Chemistry Letters. 2017 Mar 4; 7(2):280-94.
12. Klippert P, Jeanniot JP, Polvé S, Lefèvre C, Merdjan H. Determination of ivabradine and its N-demethylated metabolite in human plasma and urine, and in rat and dog plasma by a validated high-performance liquid chromatographic method with fluorescence detection. Journal of Chromatography B: Biomedical Sciences and Applications. 1998 Nov 20; 719(1):125-33.
13. Lu C, Jia Y, Yang J, Jin X, Song Y, Liu W, Ding Y, Sun X, Wen A. Simultaneous determination of ivabradine and N-desmethylivabradine in human plasma and urine using a LC-MS/MS method: application to a pharmacokinetic study. Acta Pharmaceutica Sinica B. 2012 Apr 30; 2(2):205-12.
14. Zoerner AA, Schroeder C, Kayacelebi AA, Suchy MT, Gutzki FM, Stichtenoth DO, Tank J, Jordan J, Tsikas D. A validated, rapid UPLC–MS/MS method for simultaneous ivabradine, reboxetine, and metoprolol analysis in human plasma and its application to clinical trial samples. Journal of Chromatography B. 2013 May 15; 927:105-11.
15. Guideline IH. Validation of analytical procedures: text and methodology. Q2 (R1). 2005 Nov; 1.

Published

01-09-2017
Statistics
Abstract Display: 1172
PDF Downloads: 685
Dimension Badge

How to Cite

“VALIDATED RP-HPLC METHOD FOR THE DETERMINATION OF IVABRADINE HYDROCHLORIDE IN PHARMACEUTICAL FORMULATION”. International Journal of Pharmaceutical Sciences and Drug Research, vol. 9, no. 5, Sept. 2017, pp. 228-33, https://doi.org/10.25004/IJPSDR.2017.090505.

Issue

Section

Research Article

How to Cite

“VALIDATED RP-HPLC METHOD FOR THE DETERMINATION OF IVABRADINE HYDROCHLORIDE IN PHARMACEUTICAL FORMULATION”. International Journal of Pharmaceutical Sciences and Drug Research, vol. 9, no. 5, Sept. 2017, pp. 228-33, https://doi.org/10.25004/IJPSDR.2017.090505.